Microsatellite instability in patients with stage III colon cancer receiving fluoropyrimidine with or without oxaliplatin: an ACCENT pooled analysis of 12 adjuvant trials
PURPOSE: In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant …
R Cohen, J Taieb, J Fiskum… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
[HTML][HTML] Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 …
R Cohen, J Taieb, J Fiskum, G Yothers… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
PURPOSE: In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
Microsatellite instability in stage III colon cancer patients receiving fluoropyrimidine±oxaliplatin: an
R Cohen, J Taieb, J Fiskum, G Yothers… - Journal of Clinical …, 2021 - hal.science
PURPOSE: In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant …
R Cohen, J Taieb, J Fiskum, G Yothers… - Journal of Clinical …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> PURPOSE:</jats: title>< jats: p> In patients with stage III colon
cancer (CC) whose tumors demonstrate microsatellite instability (MSI), the efficacy of …
cancer (CC) whose tumors demonstrate microsatellite instability (MSI), the efficacy of …
Microsatellite Instability in Patients with Stage III Colon Cancer Receiving Fluoropyrimidine with or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant …
R Cohen, J Taieb, J Fiskum… - Journal of Clinical …, 2021 - ohiostate.elsevierpure.com
PURPOSE: In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant …
R Cohen, J Taieb, J Fiskum, G Yothers… - Journal of Clinical …, 2020 - europepmc.org
Purpose In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
Microsatellite instability in stage III colon cancer patients receiving fluoropyrimidine±oxaliplatin: an
R Cohen, J Taieb, J Fiskum, G Yothers… - Journal of Clinical …, 2021 - inria.hal.science
PURPOSE: In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
Microsatellite instability in stage III colon cancer patients receiving fluoropyrimidine±oxaliplatin: an
R Cohen, J Taieb, J Fiskum… - Journal of Clinical …, 2021 - hal.sorbonne-universite.fr
PURPOSE: In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
Microsatellite Instability in Patients with Stage III Colon Cancer Receiving Fluoropyrimidine with or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant …
R Cohen, J Taieb, J Fiskum… - Journal of Clinical …, 2021 - mayoclinic.elsevierpure.com
PURPOSE: In patients with stage III colon cancer (CC) whose tumors demonstrate
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …
microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without …